Affera 125 mikrogram/5 mikrogram/puff Inhalationsspray, suspension

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

Bipacksedel Bipacksedel (PIL)


Produktens egenskaper Produktens egenskaper (SPC)


Aktiva substanser:
flutikasonpropionat; formoterolfumaratdihydrat
Tillgänglig från:
Mundipharma AB
INN (International namn):
fluticasone propionate; formoterol
125 mikrogram/5 mikrogram/puff
Inhalationsspray, suspension
flutikasonpropionat 125 mikrog Aktiv substans; formoterolfumaratdihydrat 5 mikrog Aktiv substans; etanol, vattenfri Hjälpämne
Receptbelagda typ:
Förpacknings: Inhalator, 120 puffar
Bemyndigande status:
Tillstånd datum:

Dokument på andra språk

Bipacksedel Bipacksedel - engelska


Produktens egenskaper Produktens egenskaper - engelska


Läs hela dokumentet


Package leaflet: Information for the user

Affera 50 microgram /5 microgram per actuation pressurised inhalation, suspension

Affera 125 microgram /5 microgram per actuation pressurised inhalation, suspension

Affera 250 microgram /10 microgram per actuation pressurised inhalation, suspension

fluticasone propionate/formoterol fumarate dihydrate

Read all of this leaflet carefully before you start using this medicine because it contains important

information for you.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor <,or> pharmacist <or nurse>.

This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if

their signs of illness are the same as yours.

If you get any side effects, talk to your doctor <,or> pharmacist <or nurse>. This includes any possible

side effects not listed in this leaflet. See section 4.

What is in this leaflet



is and what it is used for

What you need to know before you use


How to use


Possible side effects

How to store


Contents of the pack and other information


What Affera is and what it is used for

Please note:-


pressurised inhalation, suspension is the product name, however throughout this leaflet it is

shortened to


inhaler. Sometimes this may refer to a specific strength.


is an inhaler (a pressurised inhalation suspension) which contains two active ingredients:

Fluticasone propionate which belongs to a group of medicines called steroids. Steroids help to reduce

swelling and inflammation in the lungs.

Formoterol fumarate dihydrate which belongs to a group of medicines called long-acting beta


Long-acting beta

agonists are long-acting bronchodilators which help the airways in your lungs to stay

open, making it easier for you to breathe.

Together these two active ingredients help to improve your breathing. It is advised that you should use this

medicine every day as directed by your doctor.

This medicine

helps to prevent breathing problems such as asthma and helps to stop you becoming

breathless and wheezy

. However, it does not work if you are already having an asthma attack i.e. you are

already breathless and wheezing. You will need to use a fast- acting ‘reliever’ medicine such as salbutamol

if this happens.


What you need to know before you use Affera

Do not use Affera

if you:

are allergic to fluticasone propionate, formoterol fumarate or any of the other ingredients of this

medicine (listed in section 6).

Warnings and precautions

Talk to your doctor <,or> pharmacist <or nurse> before using this inhaler

Before treatment with this inhaler tell your doctor<, or> pharmacist <or nurse> if you have:

tuberculosis (TB) now or in the past. Symptoms include a persistent cough often with blood streaked

phlegm, fever, tiredness, loss of appetite, loss of weight and night sweats;

an infection of the lungs or chest;

heart problems such as problems with the blood flow to your heart or narrowing of one of your heart

valves (the aortic valve), heart failure which can cause shortness of breath or ankle swelling, a condition

where the heart muscle is enlarged (hypertrophic obstructive cardiomyopathy), an irregular heart beat

(cardiac arrhythmias) or if you have been told that your heart trace is abnormal (prolongation of the QTc


an abnormal bulging of a blood vessel wall (an aneurysm);


high blood pressure;

an overactive thyroid gland which can cause increased appetite, weight loss or sweating


low blood levels of potassium which can cause muscle weakness, twitching or abnormal heart rhythm


poor adrenal gland function (if your adrenal gland is not working properly you may have symptoms such

as headaches, weakness, tiredness, abdominal pain, loss of appetite, weight loss, dizziness, very low

blood pressure, diarrhoea, feeling or being sick or fits) or a tumor of the adrenal gland


liver problems.

Contact your doctor if you experience blurred vision or other visual disturbances.

If you are going to have an operation or are extremely stressed, please tell your doctor as you may need

additional steroid treatment to control your asthma.

Other medicines and Affera

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines

including medicines obtained without a prescription.. If you use this inhaler with some other medicines the

effect of this inhaler or the other medicine may be altered.

Tell your doctor or pharmacist if you are taking:

medicines known as beta blockers (such as atenolol to treat high blood pressure, sotalol to treat an

irregular heart beat, metoprolol to treat a fast heart beat or timolol eye drops to treat glaucoma);

certain other medicines used to treat asthma or breathing conditions (such as theophylline or


medicines containing adrenaline or related substances (including other beta agonists like salbutamol or

beta antagonists including atenolol, metoprolol, propranolol, timolol). Additional long-acting beta

agonists should not be used together with this inhaler. If your asthma becomes worse between doses of


then you should use your quick acting ‘reliever’ inhaler for immediate relief;

medicines to treat allergic reactions (antihistamines);

medicines to treat high blood pressure or fluid build up by increasing the amount of urine produced


medicines used to treat heart failure (such as digoxin);

medicines to treat abnormal heart rhythms (such as quinidine, disopyramide, procainamide);

medicines to treat symptoms of depression or mental disorders such as monoamine oxidase inhibitors

(for example phenelzine and isocarboxazid), tricyclic antidepressants (for example amitriptyline and

imipramine), or you have taken any of these types of medicine in the last two weeks;

medicines used to treat psychiatric or mental disorders (phenothiazines or antipsychotics);

other medicines containing steroids;

antifungal medicines (such as ketaconazole or itraconazole);

some medicines may increase the effects of Affera and your doctor may wish to monitor you carefully if

you are taking these medicines (including some medicines for HIV: ritonavir, atazanavir, indinavir,

nelfinavir, saquinavir or cobicistat);

antibiotics (such as clarithromycin, telithromycin or furazolidone);

medicine to treat Parkinson’s disease (levodopa);

medicine to treat an underactive thyroid gland (levothyroxine);

medicine to treat Hodgkin’s disease (procarbazine);

medicine to induce labour (oxytocin).

If you are going to have an operation under a general anaesthetic, please tell the doctor at the hospital that you

are using this inhaler.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you might be pregnant or are planning to have a baby ask your

doctor or pharmacist for advice about using your inhaler. Your doctor will advise you if you should take

this medicine.

Driving and using machines

This medicine is unlikely to affect your ability to drive or use machines.

Affera contains ethanol (alcohol) and sodium cromoglicate

This medicine contains 2 mg of alcohol in each dose (2 inhalations). The amount in each dose is equivalent

to less than 1 ml of beer or 1 ml of wine. The small amount of alcohol in this medicine will not have any

noticeable effects. It also contains a very small amount of sodium cromoglicate however patients who are

currently taking cromoglicate (used to treat asthma, allergic rhinitis and allergic conjunctivitis) should

continue as normal.


How to use Affera

Always use this inhaler exactly as your doctor or pharmacist has told you. Check with your doctor or

pharmacist if you are not sure. You should use your inhaler regularly i.e. two actuations (puffs) in the

morning and two actuations (puffs) in the evening every day to get the most benefit from your inhaler,

unless your doctor tells you otherwise or advises you to stop. Do not take more than the prescribed dose.

Your doctor may have prescribed your inhaler for a different indication other than asthma/or at a different

dose from that normally prescribed and as described in this leaflet. You should always use your inhaler

exactly as your doctor has advised. If you are not sure about how much to take or how often to use your

inhaler please check with your doctor or pharmacist.

Adults, adolescents and children aged 5 years and above

The usual dose is two inhalations twice a day, that is two puffs (actuations) in the morning and two in the

evening. Your doctor will prescribe the dose required to treat your asthma.

Only adults should use the

highest strength inhaler (Affera 250 microgram /10 microgram).

Only adults and adolescents over 12 years of age should use the medium strength inhaler (Affera

125 microgram /5 microgram).

Affera should not be used in children under 5 years of age.

Instructions for use

Read this leaflet very carefully prior to use and follow the instructions for use in the text and diagrams

below. Your doctor, or pharmacist will show you how to use your inhaler properly. The medicine is

contained in an aerosol can (see Diagram 1) which sits inside a plastic dispenser (also known as an

actuator). The actuator also has a counter to tell you how many puffs (actuations) are left after it has been

primed. This counter is colour coded. It starts off green then, when there are less than 50 puffs (actuations)

left it changes to yellow and when there are less than 30 puffs (actuations) left it changes to red. When this

is getting near to zero, you should contact your doctor for a replacement inhaler. Do not use your inhaler

when the counter reads zero.

Before you use your inhaler for the first time or if it hasn’t been used for more than 3 days or if it has

been exposed to freezing conditions

If your inhaler is new or it hasn’t been used for more than 3 days then it must be ‘primed’ to ensure it works

properly and gives you the correct dose.

If your inhaler has been exposed to freezing temperatures it must be allowed to warm at room temperature

for 30 minutes then it must be ‘primed’ to ensure it works properly and gives you the correct dose.

To prime the inhaler

Remove the mouthpiece cover and shake the inhaler well.

Point the mouthpiece away from you and release one puff (actuation) by pressing down on the aerosol

can. This step should be performed 4 times.

Your inhaler should always be shaken immediately before use.

Using your inhaler

If you feel you are getting breathless or wheezy while using


, you should continue to use


go to see your doctor as soon as possible, as you may need additional treatment. Once your asthma is well

controlled your doctor may consider it appropriate to gradually reduce the dose of


Perform steps 2 to 5 below, slowly.

Remove the mouthpiece cover (see Diagram 2) and check that your inhaler is clean and free from any


The inhaler should be shaken immediately before releasing each puff (actuation) to ensure the contents

of your inhaler are evenly mixed.

Sit upright or stand. Breathe out as far as is comfortable and as slowly and as deeply as possible.

Hold your inhaler upright (as shown in Diagram 3) and put the mouthpiece in your mouth with your lips

around it. Hold the inhaler with your thumb(s) on the base of the mouthpiece and forefinger/index

finger(s) on the top of the inhaler. Do not bite the mouthpiece.

Breathe in slowly and deeply through your mouth and, at the same time, press down on the aerosol can

to release one puff (actuation). Continue to breathe in steadily and deeply (ideally for about 2-3 seconds

in children or 4-5 seconds in adults).

While holding your breath, remove the inhaler from your mouth. Continue to hold your breath for as

long as is comfortable. Do not breathe out into the inhaler.

For the second puff (actuation), keep the inhaler in a vertical position, then repeat steps 2 to 6.

Replace the mouthpiece cover.

You can practise in front of a mirror. If you see a ‘mist’ from the top of the inhaler or around your mouth

when you use your inhaler then you may not have inhaled your medicine properly. Take another dose by

repeating from Step 2 above.

Always rinse your mouth out, gargle with water or brush your teeth after you have taken your inhaler and

spit out the residue. This may help prevent you developing a sore mouth and throat or a hoarse voice.

If you have weak hands it may be easier to hold the inhaler in both hands placing both index fingers on the

aerosol can and both thumbs on the base of the inhaler.

If you have difficulty using your inhaler your doctor may give you a device called an

AeroChamber Plus




spacer device, to help you to breathe your medicine into your lungs properly. Your doctor or

pharmacist will advise you how to use the

AeroChamber Plus




spacer device with your inhaler.

AeroChamber Plus




will come with instructions for use and with care and cleaning

instructions which you must read carefully.

Caring for your inhaler

It is important that you follow these instructions carefully and clean your inhaler weekly. To clean your


Remove the mouthpiece cover.

Do not remove the aerosol can from the actuator.

Wipe the inside and outside of the mouthpiece and the actuator with a clean, dry cloth or tissue.

Replace the mouthpiece cover.

Do not put the metal canister into water

If you use more Affera than you should

It is important that you take your dose as stated on the pharmacist’s label or as advised by your doctor. You

should not increase or decrease your dose without seeking medical advice


If you take more of your medicine than you should, contact your doctor or pharmacist for advice. You may

suffer from severe chest pain (angina), high or low blood pressure, a headache, muscle cramps, difficulty in

sleeping, nervousness, a dry mouth, a loss of appetite, seizures, fits or convulsions. You may feel shaky,

light headed, faint, tired, sick or generally unwell. You may also notice changes in the rate of your heart

beat and your blood may have low levels of potassium or an increase in the amount of sugar in your blood.

You may also suffer from symptoms such as abdominal pain, being sick, weight loss, decreased level of

consciousness (which could make you feel drowsy or confused) or a low blood sugar level.

If you have taken more than the prescribed dose for a long period of time, you should talk to your doctor or

pharmacist for advice. This is because large doses may reduce the amount of steroid hormones produced

normally by your adrenal glands (see section 4).

If you forget to use Affera

If you forget to take a dose, take it as soon as you remember

However, if it is nearly time for your next

dose, skip the missed dose. Do not take a double dose to make up for a forgotten dose.

If you stop using Affera

It is very important that you take this inhaler every day as directed by your doctor even if you feel well as it

will help to control your asthma. If you want to stop using your inhaler talk to your doctor first. Your

doctor will tell you how to do this, usually by decreasing the dose gradually so that you do not trigger an

asthma attack.


Possible side effects

Like all medicines, this inhaler

can cause side effects, although not everybody gets them. Your doctor will

prescribe the lowest dose necessary to control your asthma which may reduce the possibility of side effects


All medicines can cause allergic reactions, although serious allergic reactions are reported rarely. Tell your

doctor immediately if you get any sudden swelling of the eyelids, face, throat, tongue or lips, rash or itching

especially those covering your whole body, symptoms such as dizziness, light-headedness or fainting or any

sudden changes in your breathing pattern such as increased wheezing or shortness of breath.

As with other inhalers, your breathing may worsen immediately after using your inhaler. You may notice an

increase in wheezing and shortness of breath. If this happens stop using your


inhaler and use your

quick acting ‘reliever’ inhaler. Contact your doctor straight away. Your doctor will assess you and may

start you on a different course of treatment. You should carry your ‘reliever’ inhaler with you at all times.


may affect up to 1 in 100 people

Worsening of asthma.



An irregular heartbeat or palpitations.


Difficulty in sleeping.

Alteration in voice/hoarse voice.

Dry mouth, sore or irritated throat.



may affect up to 1 in 1,000 people

An increase in the amount of sugar in your blood. If you are diabetic you may need to check your blood

sugar more often and adjust your usual diabetic treatment. Your doctor may need to monitor you more


Thrush or other fungal infections in the mouth and throat.

Inflammation of the sinuses (sinusitis).

Fast heartbeat.

Chest pain associated with heart disease.

Muscle spasms.

Coughing or shortness of breath.



Changes in taste.

A feeling of dizziness or ‘spinning’.

Abnormal dreams.


Itchy skin.

High blood pressure.

A feeling of unusual weakness.

Swelling of hands, ankles or feet.

Not known:

frequency cannot be estimated from the available data

Blurred vision.

Sleeping problems, depression or feeling worried, aggression, anxiety, restlessness, nervousness, over-

excitment or irritability. These effects are more likely to occur in children.

The following side effects are associated with formoterol fumarate but they have not been reported during

clinical trials with this inhaler:

Low blood levels of potassium which can cause muscle weakness, twitching or abnormal heart rhythm.

An abnormal heart trace potentially leading to an abnormal heart rhythm (QTc interval prolongation).

High levels of lactic acid in the blood.

Feeling sick.

Muscle pain.

Inhaled steroids can affect the normal production of steroid hormones in your body, particularly if you use

high doses for a long time. The effects include:

changes in bone mineral density (thinning of the bones);

cataracts (clouding of the lens in the eye);

glaucoma (increased pressure in the eye);

bruising or thinning of the skin;

an increased chance of catching an infection;

slowing of the rate of growth of children and adolescents;

a round (moon shaped) face;

an effect on the adrenal gland (a small gland next to the kidney) which means you may have

symptoms such such as weakness, tiredness, difficulty in coping with stress, abdominal pain, loss of

appetite, weight loss, headache, dizziness, very low blood pressure, diarrhoea, feeling or being sick or


These effects are much less likely to happen with inhaled steroids than with steroid tablets.

Reporting of side effects

If you get any side effects, talk to your doctor<,or> pharmacist <or nurse>. This includes any possible side

effects not listed in this leaflet.

You can also report side effects directly via the national reporting system.

By reporting side effects you can help provide more information on the safety of this medicine.


How to store Affera

Keep this medicine out of the sight and reach of children.

Do not use this inhaler after the expiry date which is stated on the label, foil pouch and carton after EXP.

The expiry date refers to the last day of that month. EXP: 08-2020 means that you should not use the

inhaler after the last day of that month i.e. August 2020.

Do not store above 25°C. Do not refrigerate or freeze. If the inhaler is exposed to freezing conditions it

must be allowed to warm at room temperature for 30 minutes then primed before use (see section 3 “How to

use…”). Do not use the inhaler if it has been removed from the foil pouch for more than 3 months, or if the

dose indicator reads ‘0’.

Do not expose to temperatures higher than 50°C. The aerosol can contains a pressurised liquid so do not

puncture, break or burn the can even when apparently empty. Do not throw away any medicines via

wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use.

These measures will help protect the environment.


Contents of the pack and other information

What Affera contains

The active substances are fluticasone propionate and formoterol fumarate dihydrate. There are three

different strengths of inhaler available.

50 microgram/5 microgram per actuation

pressurised inhalation, suspension – only

Each puff (actuation) contains 50 micrograms fluticasone propionate and 5 micrograms formoterol fumarate


125 microgram/5 microgram per actuation

pressurised inhalation, suspension – only

Each puff (actuation) contains 125 micrograms fluticasone propionate and 5 micrograms formoterol

fumarate dihydrate.

250 microgram/10 microgram per actuation

pressurised inhalation, suspension – only

Each puff (actuation) contains 250 micrograms fluticasone propionate and 10 micrograms formoterol

fumarate dihydrate.

The other ingredients are:

Sodium cromoglicate


Apaflurane HFA 227 (propellant)

What Affera looks like and the contents of the pack

These inhalers are small aerosol cans containing a white to off white liquid suspension fitted with a metering

valve. The aerosol cans are inserted into grey and white plastic dispensers (actuators) with a light grey

mouthpiece cover. Each inhaler contains 120 puffs (actuations). There is one inhaler in a pack.

Marketing Authorisation Holder and Manufacturer

<To be completed nationally>

This medicinal product is authorised in the Member States of the EEA under the name Affera:



This leaflet was last revised in 2021-06-07*.

(*where date is day 90 of DCP application)

<To be completed nationally>

Trademark registration details: <To be completed Nationally.>




Section 5

How to store Affera

Put your devices and medicines you don‘t need in SIGRE point at you pharmacy.

Section 6

This leaflet was last revised in...

Detailed information on this medicinal product is available on the Spanish Agenciy of Medicines and Health

Products (SAMHP) web page

The term “asthma nurse” should be incorporated throughout the leaflet where there is a reference to doctors

and pharmacists.

Affera P0448-A R4V3 DCP 31-07-18

Läs hela dokumentet

Marknadsförs ej för närvarande.


Liknande Produkter

Sök varningar relaterade till denna produkt

Visa dokumenthistorik

Dela den här informationen